1-2 of 2
Marco Gobbi, MD, Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Potent Synergistic Activity of the NAD+ Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.

Gabriele Zoppoli, MD, Michele Cea, MD, Floriana Fruscione, Santina Bruzzone, Ph.D., Debora Soncini, Davide Bedognetti, MD, Eva Moran, Ph.D., Enrico Balleari, MD, Andrea Bruzzone, MD, Anna Garuti, Gabriella Cirmena, Ilaria Rocco, Marco Gobbi, MD, Ph.D., Riccardo Ghio, MD, Ph.D., Yves Pommier, MD, Ph.D., Angelo Michele Carella, MD, Ph.D., Alberto Ballestrero, MD, Ph.D., Silvio Parodi, MD, Ph.D., Franco Patrone, MD, Ph.D., Alessio Nencioni, MD, Ph.D.
Journal: Blood
Blood (2009) 114 (22): 2733.
https://doi.org/10.1182/blood.V114.22.2733.2733
Published: 2009
Journal Articles

Clinical and Biological EFFECTS of 5-Azacitidine FIVE Days/Monthly Schedule IN Symptomatic LOW-RISK (IPSS: 0-1) Myelodisplastic Patient.

Carla Filí, Marco Gobbi, MD, Ph.D., Giovanni Martinelli, Carlo Finelli, Ilaria Iacobucci, Emanuela Ottaviani, Lucio Cocco, MD, PhD, Matilde Y Follo, PhD, Anna Candoni, Erica Simeone, Maurizio Miglino, Francesco Lauria, MD, Monica Bocchia, Marzia Defina, Cristina Clissa, Cristina Skert, Cesare Bergonzi, Michele Malagola, Aldo M. Roccaro, MD, PhD, Annalisa Peli, Alessandro Turra, Chiara Colombi, Domenico Russo
Journal: Blood
Blood (2009) 114 (22): 4851.
https://doi.org/10.1182/blood.V114.22.4851.4851
Published: 2009